NAYA Biosciences Inc
NASDAQ:NAYA
NAYA's latest stock split occurred on Mar 18, 2025
The company executed a 1-for-12 stock split, meaning that for every 12 shares held, investors received 1 new share.
Before the split, NAYA traded at 0.2 per share. Afterward, the share price was about 2.46.
The adjusted shares began trading on Mar 18, 2025. This was NAYA's 5th stock split, following the previous one in Jul 28, 2023.
WKSP
NAYA
300803
WKHS
NAYA Biosciences Inc
Glance View
INVO BioScience, Inc. is a fertility company. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. The Company’s initial pipeline includes two novel Flex-NK Bispecific Antibodies. NY-303: its GPC3-targeted FLEX-NK Bispecific Antibody for Hepatocellular Carcinoma (HCC). NY-338: its CD38-targeted FLEX-NK Bispecific Antibody for Multiple Myeloma (MM) & Autoimmune Diseases. Its lead GPC3-targeting FLEX-NK bispecific antibody is entering Phase I/II clinical trials and positioned as a monotherapy option to address the unmet needs of the of hepatocellular carcinoma (HCC) patients not responding to standard of care with checkpoint inhibitors. INVOcell is its novel, FDA-cleared and CE-marked intravaginal culture (IVC) device. The company offers a viable alternative to vitro fertilization (IVF) that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process.
You don't have any saved screeners yet